I'm liking Geoff's comments lately
"Speed and sensitivity. Two essential elements to improve outcomes with Point of Care testing. The EuGeni platform delivers these qualities exquisitely for SARS-CoV-2 but will deliver them as well for so many more diseases and disorders in the future. EuGeni will play a role in improving health outcomes globally, something about which the team at AnteoTech can be justifiably proud. A major milestone achieved today."
the speed and accuracy we have developed from this EuGeni platform will create many more tests other than covid and sepsis. from the presentation management will be working on the seeds of these already
love the fact that operon have greater manufacturing capacity, thanks nemio, rogues and slura. also the "large scale roll out" across Europe. then Asia, then the US.
what a future Anteotech is setting up !!! gltah.
Ann: Test Platform and COVID-19 Test receive CE Mark approval, page-260
-
- There are more pages in this discussion • 700 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $67.22M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 360700 | 2.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.4¢ | 253 | 3 |
View Market Depth
| Last trade - 10.58am 12/11/2024 (20 minute delay) ? |
| ADO (ASX) Chart |
Day chart unavailable